ProQR Therapeutics
Price & Volume
Stats
See more52W Range | $1.33-$3.10 |
Market Cap | $239.9M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $13.6M |
Revenue Growth (YoY) | -57.1% |
Gross Profit (12 Mos) | $13.6M |
Diluted EPS | -$0.49 |
News
See moreYahoo Finance • 26 days ago
ProQR Prices Direct Offering And Private Placement For $59 Mln In Gross Proceeds; Stock Falls 20%
Yahoo Finance • 27 days ago
ProQR Announces Positive Phase 1 Target Engagement Data for AX-0810, Establishing First Clinical Validation of the Axiomer RNA Editing Platform
Yahoo Finance • last month
Pre-Market Movers: BYAH, LXEO, ELTX Swing Big
Yahoo Finance • 3 months ago
ProQR Announces Nomination of Dr. Lykke Hinsch Gylvin to its Board of Directors
About
CEO | Mr. Daniel Anton de Boer |
Address | Zernikedreef 9, Leiden, Netherlands, 2333 CK |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 186 |